Sugi Predict

Sugi Predict / Compounds / SCHEMBL20117015

SCHEMBL20117015

SCHEMBL20117015

CCOc1ccc(-c2noc(C3CCN(C(=O)[C@@H]4CCC(c5ccccc5)N4C(=O)OC(C)(C)C)CC3)n2)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 4/20 0.46
▸ TSHR P16473 3/20 0.45
▸ HTT P42858 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ TLR9 Q9NR96 2/20 0.42
▸ TLR8 Q9NR97 2/20 0.42
▸ TLR7 Q9NYK1 2/20 0.42
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TUBB4A P04350 1/20 0.40
▸ TUBB P07437 1/20 0.40
▸ TUBA3C P0DPH7 1/20 0.40
▸ TUBA1B P68363 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20117013 1.00 SMO (0.46) SMOTSHRHTTMEN1CYP3A4
SCHEMBL20676407 1.00 SMO (0.46) SMOTSHRHTTMEN1CYP3A4
SCHEMBL20660679 0.91 SMO (0.49) SMOTSHRHTTMEN1CYP3A4
SCHEMBL20116374 0.86 SMO (0.51) SMOTSHRHTTMEN1CYP3A4
SCHEMBL21609973 0.80 SMO (0.55) SMOTSHRHTTMEN1CYP3A4
SCHEMBL20676406 0.80 TSHR (0.51) SMOTSHRHTTMEN1CYP3A4
SCHEMBL20117108 0.80 TSHR (0.51) SMOTSHRHTTMEN1CYP3A4
SCHEMBL20116587 0.80 TSHR (0.51) SMOTSHRHTTMEN1CYP3A4
SCHEMBL20116638 0.80 TSHR (0.51) SMOTSHRHTTMEN1CYP3A4
SCHEMBL22357969 0.78 HTT (0.55) SMOTSHRHTTMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12275723-B2 Compounds and uses thereof JANSSEN PHARMACEUTICA NV (BE) 2025-04-15 — — US disclosed
US-20240400546-A1 COMPOUNDS AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2024-12-05 — — US disclosed
US-20240300938-A1 COMPOUNDS AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2024-09-12 — — US disclosed
US-11970486-B2 Compounds and uses thereof JANSSEN PHARMACEUTICA NV (BE) 2024-04-30 — — US disclosed
US-20240124435-A1 COMPOUNDS AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2024-04-18 — — US disclosed
US-11873298-B2 Compounds and uses thereof JANSSEN PHARMACEUTICA NV (BE) 2024-01-16 — — US disclosed
WO-2018081167-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS (US) 2018-05-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124435-A1 COMPOUNDS AND USES THEREOF NLN, ACHE, CLN6 SMO 1858/4885TSHR 4679/4885HTT 6/4885
US-20240300938-A1 COMPOUNDS AND USES THEREOF NLN, ACHE, CLN6 SMO 1858/4885TSHR 4679/4885HTT 6/4885
US-11873298-B2 Compounds and uses thereof NLN, ACHE, CLN6 SMO 1858/4885TSHR 4679/4885HTT 6/4885
US-20240400546-A1 COMPOUNDS AND USES THEREOF NLN, ACHE, CLN6 SMO 1858/4885TSHR 4679/4885HTT 6/4885
US-12275723-B2 Compounds and uses thereof NLN, ACHE, CLN6 SMO 1858/4885TSHR 4679/4885HTT 6/4885
US-11970486-B2 Compounds and uses thereof NLN, ACHE, CLN6 SMO 1858/4885TSHR 4679/4885HTT 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.